U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C23H27N3O2
Molecular Weight 377.4794
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of CUMYL-THPINACA

SMILES

CC(C)(NC(=O)C1=NN(CC2CCOCC2)C3=C1C=CC=C3)C4=CC=CC=C4

InChI

InChIKey=HINCNLQQLQFMRD-UHFFFAOYSA-N
InChI=1S/C23H27N3O2/c1-23(2,18-8-4-3-5-9-18)24-22(27)21-19-10-6-7-11-20(19)26(25-21)16-17-12-14-28-15-13-17/h3-11,17H,12-16H2,1-2H3,(H,24,27)

HIDE SMILES / InChI

Molecular Formula C23H27N3O2
Molecular Weight 377.4794
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Approval Year

Substance Class Chemical
Created
by admin
on Sat Dec 16 11:50:15 GMT 2023
Edited
by admin
on Sat Dec 16 11:50:15 GMT 2023
Record UNII
6R5GTC3QVB
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
CUMYL-THPINACA
Common Name English
N-(1-METHYL-1-PHENYLETHYL)-1-(TETRAHYDRO-2H-PYRAN-4-YL)METHYL-1H-INDAZOLE-3-CARBOXAMIDE
Systematic Name English
1H-INDAZOLE-3-CARBOXAMIDE, N-(1-METHYL-1-PHENYLETHYL)-1-((TETRAHYDRO-2H-PYRAN-4-YL)METHYL)-
Systematic Name English
SGT-42
Common Name English
Classification Tree Code System Code
WIKIPEDIA Designer-drugs-CUMYL-THPINACA
Created by admin on Sat Dec 16 11:50:16 GMT 2023 , Edited by admin on Sat Dec 16 11:50:16 GMT 2023
Code System Code Type Description
EPA CompTox
DTXSID401032565
Created by admin on Sat Dec 16 11:50:16 GMT 2023 , Edited by admin on Sat Dec 16 11:50:16 GMT 2023
PRIMARY
WIKIPEDIA
CUMYL-THPINACA
Created by admin on Sat Dec 16 11:50:16 GMT 2023 , Edited by admin on Sat Dec 16 11:50:16 GMT 2023
PRIMARY CUMYL-THPINACA (also known as SGT-42) is an indazole-3-carboxamide based synthetic cannabinoid. CUMYL-THPINACA acts as a potent agonist for the cannabinoid receptors, with approximately 6x selectivity for CB1, having an EC50 of 0.1nM for human CB1 receptors and 0.59nM for human CB2 receptors. Sweden's public health agency suggested to classify CUMYL-THPINACA as hazardous substance on November 10, 2014. As of October 2015 CUMYL-THPINACA is a controlled substance in China.
PUBCHEM
86273679
Created by admin on Sat Dec 16 11:50:16 GMT 2023 , Edited by admin on Sat Dec 16 11:50:16 GMT 2023
PRIMARY
FDA UNII
6R5GTC3QVB
Created by admin on Sat Dec 16 11:50:16 GMT 2023 , Edited by admin on Sat Dec 16 11:50:16 GMT 2023
PRIMARY
CAS
1400742-50-8
Created by admin on Sat Dec 16 11:50:16 GMT 2023 , Edited by admin on Sat Dec 16 11:50:16 GMT 2023
PRIMARY
MANUFACTURER PRODUCT INFORMATION
CUMYL-THPINACA
Created by admin on Sat Dec 16 11:50:16 GMT 2023 , Edited by admin on Sat Dec 16 11:50:16 GMT 2023
PRIMARY AB-CHMINACA (Item No. 15434) in a synthetic cannabinoid (CB) featuring a 1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (CHMINACA) base. It displays a 10-fold greater affinity for the central CB1 receptor (Ki = 0.9 nM) than that of JWH 018 (Item No. 10900).1,2 CUMYL-THPINACA RM is a derivative of AB-CHMINACA in which the cyclohexylmethyl group is replaced with a tetrahydropyranyl methyl group. The aminomethyloxobutanyl group of AB-CHMINACA is replaced with a cumyl group. The physiological and toxicological properties of this compound are not known. This product is intended for forensic and research applications.
Related Record Type Details
TARGET -> AGONIST
Ki
TARGET -> AGONIST
Ki
Related Record Type Details
ACTIVE MOIETY